PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryMay 9, 2001	Integra LifeSciences Reports Record First Quarter Net Income and Revenues; Earnings Before Interest, Taxes, Depreciation and Amortization Totaled $3.7 Million Integra LifeSciences Reports Record First Quarter Net Income and Revenues; Earnings Before Interest, Taxes, Depreciation and Amortization Totaled $3.7 Million PLAINSBORO, N.J.--(BUSINESS WIRE)--May 9, 2001--Led by strong growth in revenues, Integra LifeSciences Holdings Corporation (Nasdaq:IART)	View HTML Integra LifeSciences Reports Record First Quarter Net Income and Revenues; Earnings Before Interest, Taxes, Depreciation and Amortization Totaled $3.7 Million 17.8 KB
Toggle SummaryMay 25, 2001	Integra NeuroSciences' Littlejohns Honored in AACN 2001 Circle of Excellence Integra NeuroSciences' Littlejohns Honored in AACN 2001 Circle of Excellence PLAINSBORO, N.J.--(BUSINESS WIRE)--May 25, 2001--Integra NeuroSciences today announced that Linda Littlejohns, Vice President of Clinical Development, was the recipient of a Circle of Excellence Award from the American	View HTML Integra NeuroSciences' Littlejohns Honored in AACN 2001 Circle of Excellence 9.9 KB
Toggle SummaryJun 4, 2001	Integra LifeSciences Holdings Corporation Files Shelf Registration Statement Integra LifeSciences Holdings Corporation Files Shelf Registration Statement PLAINSBORO, N.J.--(BUSINESS WIRE)--June 1, 2001--Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has filed a shelf registration statement on Form S-3 with the Securities and Exchange	View HTML Integra LifeSciences Holdings Corporation Files Shelf Registration Statement 11 KB
Toggle SummaryJun 8, 2001	Integra LifeSciences to Present at the Goldman Sachs Healthcare Conference Integra LifeSciences to Present at the Goldman Sachs Healthcare Conference PLAINSBORO, N.J., Jun 8, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it is scheduled to present at the Goldman Sachs 22nd Annual Healthcare Conference in Dana Point,	View HTML Integra LifeSciences to Present at the Goldman Sachs Healthcare Conference 10.2 KB
Toggle SummaryJun 27, 2001	Integra LifeSciences Announces Completion of Grant in Advanced Biomaterials Program; Device Master File Submitted to FDA Integra LifeSciences Announces Completion of Grant in Advanced Biomaterials Program; Device Master File Submitted to FDA PLAINSBORO, N.J., Jun 27, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the successful completion of a second period of funding	View HTML Integra LifeSciences Announces Completion of Grant in Advanced Biomaterials Program; Device Master File Submitted to FDA 13 KB
Toggle SummaryJul 5, 2001	Integra LifeSciences Announces FDA Clearance for the NeuraGen Nerve Guide for Repair of Severed Peripheral Nerves Integra LifeSciences Announces FDA Clearance for the NeuraGen Nerve Guide for Repair of Severed Peripheral Nerves PLAINSBORO, N.J., Jul 5, 2001 (BUSINESS WIRE) -- Product Launch to Begin in Fourth Quarter Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that it has received	View HTML Integra LifeSciences Announces FDA Clearance for the NeuraGen Nerve Guide for Repair of Severed Peripheral Nerves 13.3 KB
Toggle SummaryJul 20, 2001	Integra LifeSciences Holdings Corporation Files Amendment to Registration Statement for Public Offering of Common Stock Integra LifeSciences Holdings Corporation Files Amendment to Registration Statement for Public Offering of Common Stock PLAINSBORO, N.J.--(BUSINESS WIRE)--July 20, 2001--Integra LifeSciences Holdings Corporation (NASDAQ: IART) today announced that it had filed an amendment to its registration	View HTML Integra LifeSciences Holdings Corporation Files Amendment to Registration Statement for Public Offering of Common Stock 11.7 KB
Toggle SummaryJul 23, 2001	Integra LifeSciences Schedules Conference Call for Thursday, August 2 to Discuss Second Quarter 2001 Results and Financial Outlook Integra LifeSciences Schedules Conference Call for Thursday, August 2 to Discuss Second Quarter 2001 Results and Financial Outlook PLAINSBORO, N.J., Jul 23, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced that it has rescheduled its conference call to	View HTML Integra LifeSciences Schedules Conference Call for Thursday, August 2 to Discuss Second Quarter 2001 Results and Financial Outlook 10.4 KB
Toggle SummaryAug 2, 2001	Integra LifeSciences Reports Record Second Quarter Net Income on 35% Growth in Product Sales Integra LifeSciences Reports Record Second Quarter Net Income on 35 PLAINSBORO, N.J.--(BUSINESS WIRE)--Aug. 2, 2001-- Earnings Before Interest, Taxes, Depreciation and Amortization Totaled $4.7 Million Led by strong growth in product sales, Integra LifeSciences Holdings Corporation (Nasdaq:IART)	View HTML Integra LifeSciences Reports Record Second Quarter Net Income on 35% Growth in Product Sales 18 KB
Toggle SummaryAug 9, 2001	Integra LifeSciences Holdings Corporation Prices Public Offering of 5,060,000 Shares of Common Stock; Integra LifeSciences Holdings Corporation Prices Public Offering of 5,060,000 Shares of Common Stock; PLAINSBORO, N.J.--(BUSINESS WIRE)--Aug. 9, 2001--Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it has priced a public offering of 5,060,000 shares of common stock at	View HTML Integra LifeSciences Holdings Corporation Prices Public Offering of 5,060,000 Shares of Common Stock; 10.2 KB